-
The Latest Information on Ruzurgi and Firdapse
Here is the latest information regarding the U.S. court ruling regarding Firdapse and Ruzurgi, brand names for amifampridine, in many LEMS patients treatment plans. This is a press release from Catalyst Pharmaceuticals. As more information becomes available, we will post it.
Sorry, there were no replies found.
Log in to reply.